Loading…
IRIDEX Corporation is projected to rise to $0.8827 by 2027, a +7% move from its current price of $0.825. IRIX is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $0.8071 | $0.8249 | $0.8431 | -0.01% |
| Aug 6 | $0.7998 | $0.8249 | $0.8507 | -0.02% |
| Aug 7 | $0.7942 | $0.8248 | $0.8565 | -0.03% |
| Aug 8 | $0.7895 | $0.8247 | $0.8615 | -0.03% |
| Aug 9 | $0.7854 | $0.8247 | $0.8658 | -0.04% |
| Aug 10 | $0.7817 | $0.8246 | $0.8698 | -0.05% |
| Aug 11 | $0.7783 | $0.8245 | $0.8735 | -0.06% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.7783 | $0.8245 | $0.8735 | -0.06% |
| Week 2 | $0.7595 | $0.824 | $0.8941 | -0.12% |
| Week 3 | $0.7452 | $0.8235 | $0.9101 | -0.18% |
| Week 4 | $0.7334 | $0.8231 | $0.9237 | -0.24% |
| Week 5 | $0.723 | $0.8226 | $0.9358 | -0.30% |
| Week 6 | $0.7138 | $0.8221 | $0.9468 | -0.35% |
| Week 7 | $0.7053 | $0.8216 | $0.957 | -0.41% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
IRIDEX Corporation is a healthcare company focused on ophthalmic medical technology. It provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments.
The company also provides delivery devices, including slit lamp adapter, which allows the physician to utilize a standard slit lamp in diagnosis and treatment procedures; TxCell scanning laser delivery system that allows the physician to perform multi-spot pattern scanning; and laser indirect ophthalmoscope for use in procedures to treat peripheral retinal disorders. In addition, it offers MicroPulse P3 Probe, which is used with its Cylco G6 laser system to perform transscleral laser therapy; G-Probe and G-Probe Illuminate, which are used in procedures to treat uncontrolled and refractory glaucoma; and EndoProbe family of products that are used for endophotocoagulation. The company serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, veterinary practices, and office clinics through direct and independent sales force in the United States, as well as through independent distributors internationally.
It operates in the United States, Europe, the Middle East, Africa, the Asia/Pacific region, and the Americas. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995.
IRIDEX Corporation was incorporated in 1989 and is headquartered in Mountain View, California.
IRIDEX Corporation, ticker IRIX, is a healthcare company focused on ophthalmic medical technology. Its current price is $0.8811 and its market cap is $15.34M, with a market rank of 4738. Its current position places it among smaller-cap healthcare stocks.
The stock trades near near-term support and resistance levels, with a 30-day range of $0.7579 to $1.02 and moving averages around $1.08 (SMA50) and $1.14 (SMA200). The longer-run price outlook, per the forecast, shows a bullish trajectory with average prices rising from $0.8811 in 2026 to $4.39 on average by 2050, with the max climbing to $7.62 in 2050. Potential returns grow across the horizon, with an expected ROI of 52.3% by 2030, rising to 150.5% by 2040 and 398.5% by 2050.
A major floor 30.5% below — a decisive break under it would weaken the trend.
Price is testing support right now (0.6% away) — a key level to hold.
The nearest ceiling, 44.2% above — a clean break opens room to run.
A major ceiling 63.6% above — clearing it would confirm fresh momentum.
Key IRIX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of IRIX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.856 | Sell | $0.852 | Sell |
| MA 10 | $0.886 | Sell | $0.8899 | Sell |
| MA 20 | $0.9755 | Sell | $0.9513 | Sell |
| MA 50 | $1.06 | Sell | $1.03 | Sell |
| MA 100 | $1.09 | Sell | $1.08 | Sell |
| MA 200 | $1.14 | Sell | $1.14 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 14.71 | Buy |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | -107.32 | Sell |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -0.01 | Sell |
| ROC (12) | -21.90 | Sell |
| Bollinger %B (20,2) | 0.13 | Neutral |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | -0.77 | Sell |
| Awesome (5,34) | -0.20 | Sell |
| Ultimate (7,14,28) | 1.55 | Buy |
| Momentum (10) | -0.11 | Sell |
| Aroon Osc (25) | -100.00 | Sell |
| Hull MA (9) | 0.83 | Sell |
| ADX (14) | 41.65 | Sell |
| ATR (14) | 0.02 | Info |
The 30-day technical picture is neutral with RSI14 at 20, suggesting limited upside momentum in the near term. The price sits around the SMA50 of $1.08 and the SMA200 of $1.14, with a nearby support at $0.89 and resistance at $1.19. The 30-day range runs from $0.7579 to $1.02, indicating a tight trading band in the near term.
Overall sentiment is NEUTRAL and annualized volatility is 40%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.82 | $0.825 | $1.01 | 0% | Neutral | |
| $0.717 | $0.8827 | $1.14 | +7% | Neutral | |
| $0.805 | $1.01 | $1.35 | +23% | Bullish | |
| $0.8778 | $1.13 | $1.54 | +36% | Bullish | |
| $0.9216 | $1.20 | $1.67 | +45% | Bullish | |
| $0.896 | $1.18 | $1.68 | +43% | Bullish | |
| $0.8969 | $1.20 | $1.73 | +46% | Bullish | |
| $0.926 | $1.26 | $1.84 | +52% | Bullish | |
| $1.00 | $1.37 | $2.04 | +67% | Bullish | |
| $1.15 | $1.59 | $2.38 | +93% | Bullish | |
| $1.30 | $1.90 | $3.01 | +131% | Bullish | |
| $2.37 | $3.76 | $6.43 | +356% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $0.82 | $0.825 | $0.9779 | +0.00% |
| September 2026 | $0.6849 | $0.8051 | $0.9695 | -2.41% |
| October 2026 | $0.6926 | $0.8187 | $0.9945 | +1.68% |
| November 2026 | $0.7042 | $0.836 | $1.02 | +2.12% |
| December 2026 | $0.6861 | $0.8179 | $1.01 | -2.17% |
Click any year to see its month-by-month IRIX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The IRIX price prediction for 2026 points to an average of $0.825 (low $0.82, high $1.01) — a potential gain of 0% on today's $0.825. A consolidation phase looks the most probable path here.
In 2027, IRIX is projected to trade between $0.717 and $1.14, averaging $0.8827 — a potential gain of +7% from today's $0.825. That is up +7% on the projected 2026 average. Price action looks broadly range-bound.
IRIDEX Corporation's 2028 outlook centres on $1.01, within a $0.805 to $1.35 range. That is up +15% on the projected 2027 average. That marks a +23% change versus current levels. Buyers look set to stay in control over this stretch.
By 2029, IRIX could reach as high as $1.54, with a base case around $1.13 and support toward $0.8778 — roughly +36% from $0.825. Momentum favours further upside here.
Expect IRIX to range from $0.9216 to $1.67 through 2030. The $1.20 average target implies a +45% move from current prices. That is up +7% on the projected 2029 average. Buyers look set to stay in control over this stretch.
The IRIX price prediction for 2031 points to an average of $1.18 (low $0.896, high $1.68) — a potential gain of +43% on today's $0.825. Momentum favours further upside here.
In 2032, IRIX is projected to trade between $0.8969 and $1.73, averaging $1.20 — a potential gain of +46% from today's $0.825. That is up +1% on the projected 2031 average. Buyers look set to stay in control over this stretch.
IRIDEX Corporation's 2033 outlook centres on $1.26, within a $0.926 to $1.84 range. That is up +5% on the projected 2032 average. That marks a +52% change versus current levels. Momentum favours further upside here.
By 2034, IRIX could reach as high as $2.04, with a base case around $1.37 and support toward $1.00 — roughly +67% from $0.825. Buyers look set to stay in control over this stretch.
Expect IRIX to range from $1.15 to $2.38 through 2035. The $1.59 average target implies a +93% move from current prices. That is up +16% on the projected 2034 average. Momentum favours further upside here.
The IRIX price prediction for 2040 points to an average of $1.90 (low $1.30, high $3.01) — a potential gain of +131% on today's $0.825. Buyers look set to stay in control over this stretch.
In 2050, IRIX is projected to trade between $2.37 and $6.43, averaging $3.76 — a potential gain of +356% from today's $0.825. That is up +98% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in IRIX today (≈ 1,212.121212 IRIX) could be worth
$4,559.6
+$3,559.6 (+356%) by 2050 · US Dollar
Based on the average projected IRIX price of $3.76 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in IRIXwould be worth at today's price.
$1,000 invested in IRIX on Jul 31, 2025 (≈ 757.575727 IRIX) would be worth
$625
-$375 (-37.5%) today · 0.62× · US Dollar
Based on a IRIX entry price of $1.32 vs. today's $0.825.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.89 | $926.97 | -7.3% |
| 1 month ago | $1.17 | $705.13 | -29.5% |
| 3 months ago | $1.03 | $800.97 | -19.9% |
| 6 months ago | $1.5 | $550 | -45.0% |
| 1 year ago | $1.32 | $625 | -37.5% |
| All time (5.0y) ago | $6.58 | $125.38 | -87.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our IRIX forecast.
Our base-case forecast reaches $1.60 around 2040.
Implied market cap at $1.60: $27.85M
Over the multi-year forecast, the average price expectation climbs from $0.8811 in 2026 to $1.34 by 2030 and further higher to $4.39 by 2050, with the max rising to $7.62 in 2050. The year-by-year averages show 2027 at $0.9668, 2028 at $1.13, 2029 at $1.24, 2030 at $1.34, 2031 at $1.32, 2032 at $1.34, 2033 at $1.43, 2034 at $1.58, and 2035 at $1.82. The forecast path is described as BULLISH from 2028 onward, with ROI progressing from 9.7% in 2027 to 52.3% in 2030, 50% in 2031, 52% in 2032, 62.4% in 2033, 78.8% in 2034, 106.6% in 2035, 150.5% in 2040, and 398.5% in 2050.
While the trajectory suggests meaningful upside, these are estimates and not guarantees, and actual results may differ.
Tap a question to reveal the answer.
The forecast for 2030 shows min $1.02, avg $1.34, max $1.89, with ROI 52.3% and sentiment BULLISH.
The long-run forecast indicates a bullish path from 2028 onward, with averages rising to $4.39 by 2050 and ROIs of 150.5% by 2040 and 398.5% by 2050. These are estimates and not guarantees.
Yes. The 2033 forecast shows min $1.05, avg $1.43, max $2.11, with a 2033 ROI of 62.4% and bullish sentiment.
Current price is $0.8811 and market cap is $15.34M.
For 2040, min $1.49, avg $2.21, max $3.54, with ROI 150.5% and sentiment BULLISH.
IRIDEX Corporation Community Discussion
0Share your IRIDEX Corporation price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.